This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sprecher, D. L. Articles by Simbartl, L. A. Search for Related Content PubMed PubMed Citation Articles by Sprecher, D. L. Articles by Simbartl, L. A.

(Circulation. 1996;94:3239-3245.)
© 1996 American Heart Association, Inc.

Articles

Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes

A Preliminary Report

Dennis L. Sprecher, MD; Betsy V. Harris, ME; Evan A. Stein, MD; Paul S. Bellet, MD; Leonard M. Keilson, MD; Loretta A. Simbartl, MS

the Cleveland Clinic Foundation (D.L.S.), Preventive Cardiology, Cleveland, Ohio; Lipid Research Division (D.L.S., B.V.H., L.A.S.), Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio; Medical Research Laboratories and The Christ Hospital Cardiovascular Research Center (E.A.S.), Cincinnati, Ohio; Department of Pediatrics (P.S.B.), Children's Hospital Medical Center, Cincinnati, Ohio; and Center for Lipids (L.M.K.), Division of Cardiology, Maine Medical Center, Portland, Me.

Background Heterozygous lipoprotein lipase (LPL) deficiency has been associated with familial hypertriglyceridemia and familial combined hyperlipidemia. Studies of heterozygotes with LPL gene defects at amino acid residues 188 and 207 showed higher triglycerides (TG) and lower HDL cholesterol (HDL-C), with no elevation in LDL cholesterol (LDL-C). Other LPL defects may reveal alternate clinical phenotypes.

Methods and Results We evaluated three families with defects at amino acid residues 64, 194, and 188. Thirty-eight heterozygotes (8 with defect 64, 14 with defect 194, and 16 with defect 188) and 95 family members without defects were studied. Plasma lipid, lipoprotein, and apolipoprotein (apo) values were measured, as well as blood pressure. Pooled carriers demonstrated higher systolic blood pressure (SBP) (127 versus 116 mm Hg, P<.0001) and TG (160 versus 125 mg/dL, P=.004) and lower HDL-C (44 versus 52 mg/dL, P=.001) than did noncarriers. A comparison of the 188 carriers and noncarriers revealed the most striking phenotypic characteristics, with lower HDL-C (36 versus 51 mg/dL, P<.0001) and HDL-C/(apo A-I + apo A-II) (0.21 versus 0.24, P=.002) and higher TG (206 versus 123 mg/dL, P=.0003), SBP (132 versus 116 mm Hg, P=.0004), and apo B/LDL-C (1.12 versus 0.93, P<.0001).

Conclusions These data confirm past observations that LPL deficient heterozygotes trend toward lower HDL-C and higher TG levels while potentially expressing higher SBP. These data also implicate the specific LPL gene defect as a contributing factor to the variable expression of HDL-C, TG, and SBP.

Key Words: lipoproteins • blood pressure • metabolism • genetics

This article has been cited by other articles:

				M. Merkel, R. H. Eckel, and I. J. Goldberg Lipoprotein lipase: genetics, lipid uptake, and regulation J. Lipid Res., December 1, 2002; 43(12): 1997 - 2006. [Abstract] [Full Text] [PDF]

				H. Allayee, T. W.A. de Bruin, K. Michelle Dominguez, L. S.-C. Cheng, E. Ipp, R. M. Cantor, K. L. Krass, E. T.P. Keulen, B. E. Aouizerat, A. J. Lusis, et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p Hypertension, October 1, 2001; 38(4): 773 - 778. [Abstract] [Full Text] [PDF]

				M. E. Wittekoek, E. Moll, S. N. Pimstone, M. D. Trip, P. J. Lansberg, J. C. Defesche, J. J. van Doormaal, M. R. Hayden, and J. J. P. Kastelein A Frequent Mutation in the Lipoprotein Lipase Gene (D9N) Deteriorates the Biochemical and Clinical Phenotype of Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2708 - 2713. [Abstract] [Full Text] [PDF]

				H. H. Wittrup, A. Tybjærg-Hansen, and B. G. Nordestgaard Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease : A Meta-Analysis Circulation, June 8, 1999; 99(22): 2901 - 2907. [Abstract] [Full Text] [PDF]

				H. E. Henderson, J. J. P. Kastelein, A. H. Zwinderman, E. Gagné, J. W. Jukema, P. W. A. Reymer, B. E. Groenemeyer, K. I. Lie, A. V. G. Bruschke, M. R. Hayden, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res., April 1, 1999; 40(4): 735 - 743. [Abstract] [Full Text]

				H. Knoblauch, A. Busjahn, S. Munter, Z. Nagy, H.-D. Faulhaber, H. Schuster, and F. C. Luft Heritability Analysis of Lipids and Three Gene Loci in Twins Link the Macrophage Scavenger Receptor to HDL Cholesterol Concentrations Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2054 - 2060. [Abstract] [Full Text]

				B. G. Nordestgaard, S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjærg-Hansen Heterozygous Lipoprotein Lipase Deficiency : Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease Circulation, September 16, 1997; 96(6): 1737 - 1744. [Abstract] [Full Text]